ERT: Clinical Trial Technology Solutions

ERT (rebranded as Clario in 2021 following a merger with Bioclinica) is a clinical trial technology company providing eCOA/ePRO electronic outcome assessment platforms, cardiac safety, and respiratory services for drug development, including FDA-validated psychiatric rating scale libraries and eC-SSRS suicide-ideation monitoring used in psychedelic and ketamine trials. The company has supported over 3,500 clinical trials and underpinned more than 60% of 2017 FDA treatment approvals.